- President, University Hospitals, University Hospitals
- Chair, Auditory Surgery and Hearing Sciences, UH Cleveland Medical Center
- Professor, CWRU School of Medicine
Cliff A. Megerian, MD, will assume the position of System CEO in January 2021 upon the retirement of Thomas F. Zenty III, who has served as CEO since 2003. Until that time, Dr. Megerian will serve as President of University Hospitals Health System (UH), which was effective December 2019. Headquartered in Cleveland, Ohio, UH is a $4-plus billion comprehensive health system and serves the needs of over one million patients through an integrated network of 18 hospitals, more than 50 health centers and outpatient facilities, and 200 physicians offices in 16 counties throughout northern Ohio. The system’s flagship academic medical center, University Hospitals Cleveland Medical Center, is affiliated with Case Western Reserve University School of Medicine. The main campus also includes UH Rainbow Babies & Children's Hospital, UH MacDonald Women's Hospital, and UH Seidman Cancer Center. UH is the region’s second-largest employer with more than 28,000 caregivers.
Previously, Dr. Megerian served as President of University Hospitals Physician Network and System Institutes – a position he held since 2018. The Network includes over 2,500 UH employed physicians. The UH System Institutes bring highly trained sub-specialists together from multiple disciplines to collaborate on the best treatment for patients spanning 14 clinical care areas. Institutes also promote uniform, standard care protocols, and the sharing of best practices.
Before that role, Dr. Megerian served as President, University Hospitals Physician Services. UH’s physician network includes the full-time academic medical practice at UH Cleveland Medical Center and UH’s community-based, multi-specialty physician network throughout Northeast Ohio.
Dr. Cliff Megerian is also a Professor in the Department of Otolaryngology, Head and Neck Surgery, at Case Western Reserve University School of Medicine, where he was Chair from 2012-2018. In 2008, he was named the inaugural recipient of the Richard W. and Patricia R. Pogue Endowed Chair in Auditory Surgery and Hearing Sciences at UH Cleveland Medical Center. As a surgeon, Dr. Megerian co-founded UH’s Cochlear implant program, and he and his team have performed over 1,000 cochlear implant surgeries, making it one of the country's largest programs. He joined UH in 2002.
Before UH, Dr. Megerian served on the Louis Stokes Cleveland Veteran Affairs Medical Center's physician staff, Metro Health System Medical Center, and Boston Medical Center. Additionally, Dr. Megerian worked at the University of Massachusetts Medical Center, where he served as Director of Residency Training, Physician Unit Chief, Department of Audiology, Medical Director, Cochlear Implantation Program, Co-Director, Center for Skull Base Diseases, and Director of Otology and Neurotology in the Department of Otolaryngology.
Dr. Megerian’ s clinical career is devoted to managing hearing loss, chronic ear disease, cholesteatoma, otosclerosis, vertigo, and other otology and neurotolgy issues. He is also an expert in the diagnosis and treatment of an acoustic neuroma. He has published over 120 peer-reviewed manuscripts and abstracts and has served as a visiting professor at numerous medical schools and institutions worldwide. His research interests in the pathogenesis of Meniere’s disease have been funded by many agencies, including the NIH and DRF. He sits on the Editorial Board of key journals in his field and has been selected by the FDA to serve as a consultant in the regulation of Ear, Nose, and Throat Devices. The American Academy of Otolaryngology has appointed him to represent the Academy on the Joint Committee on Infant Hearing (JCHI).
Dr. Megerian is a graduate of the University of Michigan Medical School and completed a residency in otolaryngology at Case Western Reserve University. He completed a research and clinical fellowship in otology and neurotology at Harvard Medical School, Massachusetts Eye, and Ear Infirmary. In 2009 he completed a certificate program in healthcare management at Weatherhead School of Business at Case Western Reserve University. In 2017, Dr. Megerian was elected for a six-year term on the American Hospital Association’s Regional Policy Board.
Dr. Megerian resides in Shaker Heights along with his wife, Lynne. They have three children, Drew, Mark, and Caroline.
- Acoustic Neuromas
- Chronic Ear Disease
- Cochlear Implantation
- Ear, Nose and Throat
- Head and Neck Cancer
- Hearing Loss
- Meniere's Disease
- Skull Base Surgery
- Surgery for Hearing Loss and Tumor
Patient Experience Reviews
5.0 out of 5
Patient Comments (2)
Reviewed On 3/1/2021
Dr. Megarian is personable, well-prepared, is a genius! He saved my life by finding a condition that other doctors missed. He is the greatest!
Reviewed On 9/1/2020
We absolutely love Dr Megerian. He has so much respect for his patient's.
- Neurotology - American Board of Otolaryngology - Head and Neck Surgery
- Otolaryngology - Head and Neck Surgery - American Board of Otolaryngology - Head and Neck Surgery
Fellowship | Otology and Neurotology
Otology and Neurotology - Massachusetts Eye And Ear Infirmary (1993 - 1995)
Residency | Otolaryngology
Otolaryngology - University Hospitals Of Cleveland (1989 - 1993)
Internship | General Surgery
General Surgery - University Hospitals Of Cleveland (1988 - 1989)
University Of Michigan Medical School (1988)
Michigan State University (1984)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Cliff Megerian did not disclose any Outside Relationships with Industry.